[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release",
    "summary": "Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=c9cc0317beb25cbb2f524e8948b1560ae90be6931c0a5a87d87a113a72b382e7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745848840,
      "headline": "Vertex Pharmaceuticals (VRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release",
      "id": 134115331,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "Vertex (VRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=c9cc0317beb25cbb2f524e8948b1560ae90be6931c0a5a87d87a113a72b382e7"
    }
  },
  {
    "ts": null,
    "headline": "My 5 Top Stocks to Buy Right Now in This Highly Volatile Market",
    "summary": "The major market indexes are behaving like a frantic yo-yo, swinging up or down depending on the latest tariff- or Fed-related news from the White House.  You can still find attractive stocks despite all of the turbulence.  Here are my five top stocks to buy right now in this highly volatile market.",
    "url": "https://finnhub.io/api/news?id=9c91bc8ed1f617458ab141d77afce597910a92f4723465995672684a4a7e4cea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745830080,
      "headline": "My 5 Top Stocks to Buy Right Now in This Highly Volatile Market",
      "id": 134115304,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VRTX",
      "source": "Yahoo",
      "summary": "The major market indexes are behaving like a frantic yo-yo, swinging up or down depending on the latest tariff- or Fed-related news from the White House.  You can still find attractive stocks despite all of the turbulence.  Here are my five top stocks to buy right now in this highly volatile market.",
      "url": "https://finnhub.io/api/news?id=9c91bc8ed1f617458ab141d77afce597910a92f4723465995672684a4a7e4cea"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Receives CHMP Positive Opinion for ALYFTREK速, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis",
    "summary": "ALYFTREK速 recommended for people with CF ages 6 years and older with at least one non-class I mutation in the CFTR gene -- In head-to-head clinical trials, deutivacaftor/tezacaftor/vanzacaftor...",
    "url": "https://finnhub.io/api/news?id=dd6a29516e8047bd825248ffc1f5eed751d99d751e132380fb391ece1ae5307d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745805843,
      "headline": "Vertex Receives CHMP Positive Opinion for ALYFTREK速, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis",
      "id": 134111226,
      "image": "",
      "related": "VRTX",
      "source": "Finnhub",
      "summary": "ALYFTREK速 recommended for people with CF ages 6 years and older with at least one non-class I mutation in the CFTR gene -- In head-to-head clinical trials, deutivacaftor/tezacaftor/vanzacaftor...",
      "url": "https://finnhub.io/api/news?id=dd6a29516e8047bd825248ffc1f5eed751d99d751e132380fb391ece1ae5307d"
    }
  }
]